» Articles » PMID: 36555918

Knee Osteoarthritis in Relation to the Risk Factors of the Metabolic Syndrome Components and Environment of Origin

Overview
Journal J Clin Med
Specialty General Medicine
Date 2022 Dec 23
PMID 36555918
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Knee osteoarthritis (KOA) is a chronic degenerative pathology that is associated with multiple risk factors such as age, sex, obesity, or metabolic syndrome (MetS). The present clinical trial aimed to investigate the influence of the environment of origin, body mass index (BMI), and MetS parameters on the KOA differentiated degrees. Methods: 85 patients were admitted for the clinical study. The KOA presence was investigated using X-rays analysis. The Kellgren−Lawrence classification (KL) of the KOA severity and the MetS characteristic parameters using freshly collected blood were performed for each patient. All data collected were used for ANOVA statistic interpretation. Results: The total cholesterol and glycemia were found to be statistically significant (p < 0.028, and p < 0.03, respectively), with a high level in patients with severe KOA compared to healthy ones. Patients from rural regions are 5.18 times more prone to develop severe KOA when compared to ones from urban areas. Conclusions: The results of the statistical analysis confirmed the correlation between the incidence and severity of KOA and the influence of increased values of BMI, glycemia, triglycerides, and total cholesterol. The investigations revealed a statistically significant influence of the environment of origin on the KOA degree of the patients.

Citing Articles

Non-linear associations between blood glucose, blood lipids and inflammatory markers and new-onset arthritis in the middle-aged and older population - a cohort study in Europe.

Qiu F, Li J, Legerlotz K Lipids Health Dis. 2025; 24(1):79.

PMID: 40025473 PMC: 11872311. DOI: 10.1186/s12944-025-02495-9.


Analysis of Synovial Fluid Metabolic Profile in Patients with Knee Osteoarthritis Using Spectroscopic Magnetic Resonance Metabolomics.

Alves P, Aguiar D, Ladeira A, Santos G, de Sousa E Rev Bras Ortop (Sao Paulo). 2024; 59(6):e958-e965.

PMID: 39711625 PMC: 11663051. DOI: 10.1055/s-0044-1790217.


The association between ADAMTS14/rs4747096 gene polymorphism and some risk factors and knee osteoarthritis.

Elshaarawy G, Salama I, Salama S, Abdelrahman A, Hassan M, Eissa E BMC Musculoskelet Disord. 2024; 25(1):867.

PMID: 39472918 PMC: 11523595. DOI: 10.1186/s12891-024-07943-8.


Regulating lipid metabolism in osteoarthritis: a complex area with important future therapeutic potential.

Chen X, Liu J, Wang G, Sun Y, Ding X, Zhang X Ann Med. 2024; 56(1):2420863.

PMID: 39466361 PMC: 11520103. DOI: 10.1080/07853890.2024.2420863.


Current Evidence on and Clinical Implications of Vitamin D Levels in Pain and Functional Management of Knee Osteoarthritis: A Systematic Review.

Georgescu B, Cristea A, Oprea D, Lupu A, Stanciu L, Borgazi E Clin Pract. 2024; 14(5):1997-2012.

PMID: 39451873 PMC: 11506653. DOI: 10.3390/clinpract14050158.


References
1.
Williams M, London D, Husni E, Navaneethan S, Kashyap S . Type 2 diabetes and osteoarthritis: a systematic review and meta-analysis. J Diabetes Complications. 2016; 30(5):944-50. DOI: 10.1016/j.jdiacomp.2016.02.016. View

2.
Courties A, Sellam J . Osteoarthritis and type 2 diabetes mellitus: What are the links?. Diabetes Res Clin Pract. 2016; 122:198-206. DOI: 10.1016/j.diabres.2016.10.021. View

3.
Boring M, Hootman J, Liu Y, Theis K, Murphy L, Barbour K . Prevalence of Arthritis and Arthritis-Attributable Activity Limitation by Urban-Rural County Classification - United States, 2015. MMWR Morb Mortal Wkly Rep. 2017; 66(20):527-532. PMC: 5657875. DOI: 10.15585/mmwr.mm6620a2. View

4.
Einhorn D, Reaven G, Cobin R, Ford E, Ganda O, Handelsman Y . American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2003; 9(3):237-52. View

5.
Buchele G, Gunther K, Brenner H, Puhl W, Sturmer T, Rothenbacher D . Osteoarthritis-patterns, cardio-metabolic risk factors and risk of all-cause mortality: 20 years follow-up in patients after hip or knee replacement. Sci Rep. 2018; 8(1):5253. PMC: 5869736. DOI: 10.1038/s41598-018-23573-2. View